Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KOD Kodiak Sciences Inc.

交易中 11-22 13:19:38 EST

6.21

+0.31

+5.25%

最高6.28	最低5.79	成交量14.37万
今开5.90	昨收5.90	日振幅8.31%
总市值3.26亿	流通市值2.00亿	总股本5,250万
成交额87.60万	换手率0.45%	流通股本3,221万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KOD","market":"US","secType":"STK","nameCN":"Kodiak Sciences Inc.","latestPrice":6.21,"timestamp":1732299576082,"preClose":5.9,"halted":0,"volume":143666,"delay":0,"floatShares":32214858,"shares":52501425,"eps":-3.646996,"marketStatus":"交易中","marketStatusCode":2,"change":0.31,"latestTime":"11-22 13:19:38 EST","open":5.9,"high":6.28,"low":5.79,"amount":876006.8398842,"amplitude":0.083051,"askPrice":6.23,"askSize":300,"bidPrice":6.2,"bidSize":310,"shortable":3,"etf":0,"ttmEps":-3.646996,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1538625600000,"adjPreClose":5.9,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5.89,"preClose":5.9,"latestTime":"08:00 EST","volume":25,"amount":147.25,"timestamp":1732280400403},"postHourTrading":{"tag":"盘后","latestPrice":5.89,"preClose":5.9,"latestTime":"19:32 EST","volume":958,"amount":5661.01,"timestamp":1732235579239},"volumeRatio":0.509398,"impliedVol":0.3876,"impliedVolPercentile":0.2778},"requestUrl":"/m/hq/s/KOD","defaultTab":"news","newsList":[{"id":"2484749106","title":"Kodiak Sciences Inc盘中异动 大幅拉升5.15%报5.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484749106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484749106?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:01","pubTimestamp":1731942109,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时01分，Kodiak Sciences Inc股票出现异动，股价快速上涨5.15%。截至发稿，该股报5.82美元/股，成交量3.4558万股，换手率0.07%，振幅6.24%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.62%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230149971a7333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230149971a7333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"2483242103","title":"科迪亚克科学公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483242103","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483242103?lang=zh_cn&edition=full","pubTime":"2024-11-15 20:00","pubTimestamp":1731672016,"startTime":"0","endTime":"0","summary":"科迪亚克科学公司公布截至 9 月 30 日的季度业绩 - 收益摘要科迪亚克科学公司KOD.OQ公布，在截至9月30日的季度调整后每股亏损84美分，高于去年同期的每股-95美分。六位分析师对该季度的平均预期是每股亏损 90 美分。该公司当季亏损 4,395 万美元。科迪亚克科学公司股价本季度上涨了 103.1%，今年迄今为止上涨了 74.3%。华尔街对科迪亚克科学公司 12 个月目标价的中位数为 3.50 本摘要由 LSEG 11 月 15 日上午 11:59 时的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4S3MM0UE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KOD"],"gpt_icon":0},{"id":"2483384308","title":"Kodiak Sciences Inc   预计每股亏损 90 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483384308","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483384308?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:45","pubTimestamp":1731512702,"startTime":"0","endTime":"0","summary":"   * 科迪亚克科学公司   预计在11月15日公布截至2024年9月30日的业绩时，季度收入将不会有任何变化(预计)。*    * LSEG的分析师平均预计科迪亚克科学公司每股亏损90美分。* 华尔街对 Kodiak Sciences Inc 的 12 个月目标价中位数为 3.00 美元，低于其上次收盘价 5.08 美元。11月13日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kodiak Sciences Inc   预计每股亏损 90 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"gpt_icon":0},{"id":"2483881284","title":"Kodiak Sciences Inc盘中异动 股价大涨6.50%报5.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881284?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:41","pubTimestamp":1731508914,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时41分，Kodiak Sciences Inc股票出现异动，股价急速拉升6.50%。截至发稿，该股报5.41美元/股，成交量4145股，换手率0.01%，振幅3.44%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.30%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224154a2345997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224154a2345997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KOD","BK4505"],"gpt_icon":0},{"id":"2483843052","title":"Kodiak Sciences Inc盘中异动 临近收盘急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483843052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483843052?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:59","pubTimestamp":1731445141,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时59分，Kodiak Sciences Inc股票出现异动，股价快速跳水5.06%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为1.05%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kairos Pharma, Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Genprex, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为594.90%、508.70%、284.38%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为209.30%、105.45%、86.87%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113045901abbaf9b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113045901abbaf9b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"gpt_icon":0},{"id":"2482751057","title":"Kodiak Sciences Inc盘中异动 下午盘大幅拉升5.18%报5.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482751057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482751057?lang=zh_cn&edition=full","pubTime":"2024-11-12 02:46","pubTimestamp":1731350783,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日02时46分，Kodiak Sciences Inc股票出现波动，股价快速拉升5.18%。截至发稿，该股报5.18美元/股，成交量19.628万股，换手率0.37%，振幅6.00%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.71%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111202462498e41de2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111202462498e41de2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","ALGS","KOD"],"gpt_icon":0},{"id":"2481483942","title":"Kodiak Sciences Inc 预计每股亏损 90 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483942","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481483942?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:50","pubTimestamp":1731081049,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc 预计每股亏损 90 美分 - 财报前瞻科迪亚克科学公司KOD.OQ KOD.O预计在11月12日公布截至2024年9月30日的业绩时，季度收入将不会有任何变化(预计)。LSEG的分析师平均预计科迪亚克科学公司每股亏损90美分。华尔街对 Kodiak Sciences Inc 的 12 个月目标价中位数为 3.00 美元，低于其上次收盘价 4.81 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF1RZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD"],"gpt_icon":0},{"id":"2481985534","title":"Kodiak Sciences Inc盘中异动 早盘大幅拉升5.02%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985534?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903505,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Kodiak Sciences Inc股票出现异动，股价急速上涨5.02%。截至发稿，该股报4.60美元/股，成交量1.5216万股，换手率0.03%，振幅1.60%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.91%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145a21d2a33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145a21d2a33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"gpt_icon":0},{"id":"2481867736","title":"Kodiak Sciences Inc盘中异动 急速上涨5.13%报4.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481867736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481867736?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:07","pubTimestamp":1730819266,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日23时07分，Kodiak Sciences Inc股票出现异动，股价急速拉升5.13%。截至发稿，该股报4.10美元/股，成交量4.9014万股，换手率0.09%，振幅4.87%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.98%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105230746971a4749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105230746971a4749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"2480068974","title":"Kodiak Sciences Inc盘中异动 急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480068974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480068974?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:59","pubTimestamp":1730401146,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时59分，Kodiak Sciences Inc股票出现波动，股价大幅下跌5.06%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为3.38%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Quince Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为274.53%、243.55%、197.72%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Promis Neurosciences Inc.、Vaccinex, Inc.，振幅分别为80.77%、51.56%、47.15%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101025906ab8cfd6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101025906ab8cfd6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"2479152289","title":"Kodiak Sciences Inc盘中异动 大幅上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479152289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479152289?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:22","pubTimestamp":1730211728,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日22时22分，Kodiak Sciences Inc股票出现波动，股价大幅拉升5.09%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Glycomimetics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为627.78%、510.37%、297.63%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为160.88%、88.24%、65.41%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102922220898e3f20f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102922220898e3f20f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4139","BK4505"],"gpt_icon":0},{"id":"2478530953","title":"Kodiak Sciences Inc盘中异动 临近午盘股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478530953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478530953?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:57","pubTimestamp":1729871829,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时57分，Kodiak Sciences Inc股票出现异动，股价急速拉升5.25%。截至发稿，该股报3.61美元/股，成交量6.5906万股，换手率0.13%，振幅5.25%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.69%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025235709971a25e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025235709971a25e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4505","KOD","BK4139","ELAB"],"gpt_icon":0},{"id":"2477534151","title":"Kodiak Sciences Inc盘中异动 大幅下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477534151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477534151?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:33","pubTimestamp":1729694010,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时33分，Kodiak Sciences Inc股票出现异动，股价快速下挫5.07%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Virax Biolabs Group Limited涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1629.90%、1005.72%、342.88%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为71.86%、68.32%、64.81%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023223330a1e421ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023223330a1e421ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"2476019661","title":"Kodiak Sciences Inc盘中异动 股价大涨5.00%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476019661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476019661?lang=zh_cn&edition=full","pubTime":"2024-10-18 00:08","pubTimestamp":1729181308,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日00时08分，Kodiak Sciences Inc股票出现异动，股价急速上涨5.00%。截至发稿，该股报3.15美元/股，成交量12.849万股，换手率0.24%，振幅6.67%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.80%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018000829971a0e27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018000829971a0e27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4139","BK4505"],"gpt_icon":0},{"id":"2474046836","title":"Kodiak Sciences Inc盘中异动 下午盘快速上涨5.13%报2.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474046836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474046836?lang=zh_cn&edition=full","pubTime":"2024-10-12 02:30","pubTimestamp":1728671450,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日02时30分，Kodiak Sciences Inc股票出现波动，股价急速上涨5.13%。截至发稿，该股报2.83美元/股，成交量11.9376万股，换手率0.23%，振幅6.13%。机构评级方面，在所有7家参与评级的机构中，14%的券商给予买入建议，43%的券商给予持有建议，43%的券商给予卖出建议。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为1.60%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241012023050ab697aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241012023050ab697aac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"gpt_icon":0},{"id":"2472952155","title":"Kodiak Sciences Inc盘中异动 快速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472952155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472952155?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:30","pubTimestamp":1728048648,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时30分，Kodiak Sciences Inc股票出现波动，股价快速拉升5.38%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Aditxt, Inc.、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Aditxt, Inc.、Elevai Labs, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为1289.57%、15.34%、12.70%，振幅较大的相关个股有Estrella Immunopharma, Inc.、Cero Therapeutics Holdings, Inc.、Oncolytics Biotech Inc.，振幅分别为8.11%、5.09%、4.30%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004213048ab67bc34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004213048ab67bc34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"2470136761","title":"Kodiak Sciences Inc盘中异动 下午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470136761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470136761?lang=zh_cn&edition=full","pubTime":"2024-09-27 03:10","pubTimestamp":1727377825,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日03时10分，Kodiak Sciences Inc股票出现波动，股价大幅拉升5.00%。截至发稿，该股报2.73美元/股，成交量12.0779万股，换手率0.23%，振幅5.77%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.27%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927031025a1dcca61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927031025a1dcca61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4505","BK4139","KTTA"],"gpt_icon":0},{"id":"2469243361","title":"Kodiak Sciences Inc盘中异动 股价大跌5.30%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469243361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469243361?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:22","pubTimestamp":1727119357,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时22分，Kodiak Sciences Inc股票出现波动，股价快速下跌5.30%。截至发稿，该股报2.50美元/股，成交量17.3147万股，换手率0.33%，振幅5.88%。机构评级方面，在所有6家参与评级的机构中，50%的券商给予持有建议，50%的券商给予卖出建议，无券商给予买入建议。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为2.49%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924032238ab656521&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924032238ab656521&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4139","BK4505"],"gpt_icon":0},{"id":"2460068992","title":"Kodiak Sciences Inc盘中异动 大幅上涨5.26%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460068992","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460068992?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:16","pubTimestamp":1724091385,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时16分，Kodiak Sciences Inc股票出现异动，股价快速拉升5.26%。截至发稿，该股报2.60美元/股，成交量7.2369万股，换手率0.14%，振幅4.86%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为1.27%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820021625a1d50878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820021625a1d50878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD","BK4539"],"gpt_icon":1},{"id":"2460710829","title":"Kodiak Sciences Inc2024财年第二财季实现净利润-45.12百万美元，同比增加43.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460710829","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460710829?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:01","pubTimestamp":1723996861,"startTime":"0","endTime":"0","summary":"8月19日，Kodiak Sciences Inc公布财报，公告显示公司2024财年第二财季净利润为-45.12百万美元，同比增加43.73%；其中营业收入为0.00美元，每股基本收益为-0.86美元。从资产负债表来看，Kodiak Sciences Inc总负债1.87亿美元，其中短期债务9.89百万美元，资产负债比为2.15，流动比率为0.11。机构评级：截至2024年8月19日，当前有3家机构对Kodiak Sciences Inc目标价做出预测，其中目标均价为2.67美元，其中最低目标价为2.00美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190001119f363b24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190001119f363b24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kodiak.com","stockEarnings":[{"period":"1week","weight":0.1132},{"period":"1month","weight":0.6164},{"period":"3month","weight":1.0557},{"period":"6month","weight":0.9218},{"period":"1year","weight":1.4583},{"period":"ytd","weight":0.9408}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kodiak Sciences Inc.于2009年6月22日以Oligasis LLC的名义成立为有限责任公司。2015年9月8日更名并在特拉华州注册成立公司。该公司是一家临床阶段的生物制药公司，专门研究治疗慢性高流行性视网膜疾病的新疗法。Kodiak Sciences Inc.最先进的候选产品是KSI-301，一种用抗体生物聚合物共轭平台或ABC平台构建的生物疗法，旨在维持眼组织中有效和有效的药物水平。Kodiak Sciences Inc.认为，如果获得批准，KSI-301有可能成为湿性年龄相关性黄斑变性，湿性AMD和糖尿病性视网膜病变或DR的重要抗VEGF治疗。KSI-301及其ABC平台是在Kodiak开发的，他们拥有这些资产的全球权利，包括KSI-301的物质专利保护组成。Kodiak Sciences Inc.已经应用他们的ABC平台开发了除KSI-301之外的其他候选产品，包括KSI-501，他们的双特异性抗IL-6/VEGF生物共轭物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.011633},{"month":2,"riseRate":0.5,"avgChangeRate":-0.09488},{"month":3,"riseRate":0,"avgChangeRate":-0.119998},{"month":4,"riseRate":0.5,"avgChangeRate":-0.092981},{"month":5,"riseRate":0.666667,"avgChangeRate":0.125856},{"month":6,"riseRate":0.666667,"avgChangeRate":0.015307},{"month":7,"riseRate":0.5,"avgChangeRate":-0.036052},{"month":8,"riseRate":0.5,"avgChangeRate":-0.040602},{"month":9,"riseRate":0.666667,"avgChangeRate":0.013919},{"month":10,"riseRate":0.666667,"avgChangeRate":0.230496},{"month":11,"riseRate":0.714286,"avgChangeRate":0.27164},{"month":12,"riseRate":0.5,"avgChangeRate":0.237125}],"exchange":"NASDAQ","name":"Kodiak Sciences Inc.","nameEN":"Kodiak Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kodiak Sciences Inc.(KOD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kodiak Sciences Inc.,KOD,Kodiak Sciences Inc.股票,Kodiak Sciences Inc.股票老虎,Kodiak Sciences Inc.股票老虎国际,Kodiak Sciences Inc.行情,Kodiak Sciences Inc.股票行情,Kodiak Sciences Inc.股价,Kodiak Sciences Inc.股市,Kodiak Sciences Inc.股票价格,Kodiak Sciences Inc.股票交易,Kodiak Sciences Inc.股票购买,Kodiak Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kodiak Sciences Inc.(KOD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}